헬스케어 분야 인지 기능 평가 및 트레이닝 시장 예측(-2030년) : 구성요소별, 평가별, 용도별, 최종 사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Cognitive Assessment & Training in Healthcare Market is accounted for $3.42 billion in 2023 and is expected to reach $26.67 billion by 2030 growing at a CAGR of 25.6% during the forecast period. Cognitive assessment and training play crucial roles in healthcare, evaluating and enhancing cognitive functions. These tools help clinicians identify and address cognitive impairments, providing insights into patients' mental health. Integrating these tools into healthcare facilitates early detection of cognitive decline and enables personalized interventions, contributing to more effective patient care and management of conditions like dementia and other cognitive disorders.

According to Alzheimer's Association, more than 153 million individuals will develop dementia by 2050, up from 57 million in 2019.

Market Dynamics:

Driver:

Increasing aging population

As the elderly demographic expands, there is a growing demand for effective cognitive health solutions. This has prompted the healthcare industry to focus on innovative assessments and training programs to address age-related cognitive decline, dementia, and other neurodegenerative disorders. The market is witnessing an upsurge in technological advancements and personalized approaches to cater to the specific cognitive needs of the aging population, driving the overall growth and development of cognitive healthcare solutions.

Restraint:

Data privacy & security concerns

Sensitive patient information is increasingly digitized for assessments, the risk of unauthorized access and data breaches poses a substantial threat. Issues include unauthorized access to personal health information, potential breaches compromising patient confidentiality, and the need for robust encryption measures. As these assessments often involve advanced technologies, ensuring compliance with data protection regulations, such as HIPAA, becomes crucial to safeguarding patient privacy and maintaining trust in the healthcare ecosystem.

Opportunity:

Integration with electronic health records (EHR)

Seamless connectivity between cognitive health data and EHR streamlines patient care, enhances diagnostic accuracy, and facilitates personalized interventions. This integration enables healthcare providers to leverage comprehensive patient profiles, fostering a holistic approach to cognitive well-being. As the demand for cognitive health solutions grows, aligning with EHR systems ensures a cohesive and efficient healthcare ecosystem, ultimately improving patient outcomes and advancing the field of cognitive healthcare.

Threat:

High initial costs

Implementing cognitive solutions requires substantial financial investment, hindering widespread adoption among healthcare providers. The creation of accurate and clinically validated assessments, along with the development of effective training programs, demands substantial research and development investments. Also, implementing secure data storage further contributes to the initial expenses. This challenge may impede the integration of advanced cognitive technologies, limiting access to innovative assessment and training tools.

COVID-19 Impact

The COVID-19 pandemic has had multifaceted effects on healthcare. It significantly impacted the Cognitive Assessment and Training in Healthcare Market, with increased focus on remote solutions. Lockdowns and social distancing measures accelerated the adoption of virtual platforms for cognitive assessments and training, addressing the need for at-home healthcare. The industry witnessed a surge in demand for digital cognitive health tools, reshaping the market landscape.

The pen & paper based assessment segment is expected to be the largest during the forecast period

The pen & paper based assessment segment is estimated to have a lucrative growth. Pen and paper-based assessments remain prevalent in the Cognitive Assessment and Training sector within the Healthcare market. Despite technological advancements, these traditional methods offer a cost-effective and widely accessible means of evaluating cognitive functions. They continue to play a crucial role in baseline assessments and monitoring cognitive decline. It enhances accuracy and efficiency in cognitive evaluations while adapting to evolving healthcare trends.

The clinical trials segment is expected to have the highest CAGR during the forecast period

The clinical trials segment is anticipated to witness the highest CAGR growth during the forecast period. These trials focus on assessing and improving mental processes such as memory, attention, and problem-solving. In the healthcare market, they contribute to the development of effective interventions for conditions like Alzheimer's and cognitive impairments. The evolving landscape of cognitive healthcare continues to benefit from ongoing research and innovation in this field.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing aging population, rising awareness of cognitive health, and technological advancements. The region is home for key players such as Cambridge Cognition Ltd., CogniFit Inc., Cogstate Ltd. and Brain Resource Company. These companies are rapidly expanding their healthcare infrastructure. Government's focus on healthcare infrastructure and the adoption of digital health solutions further drive the market.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to increasing adoption of innovative technologies for cognitive evaluation and enhancement. With a focus on addressing neurological disorders and promoting mental well-being, the market has witnessed a surge in demand for personalized, technology-driven solutions. Key players in the region are actively collaborating with healthcare providers to deliver advanced cognitive assessment tools and training programs, contributing to the overall improvement of patient outcomes and the advancement of neurocognitive healthcare practices.

Key players in the market:

Some of the key players profiled in the Cognitive Assessment & Training in Healthcare Market include Cambridge Cognition Ltd, CogniFit Inc, Cogstate Ltd, Eisai Limited, Brain Resource Company, WIRB-Copernicus Group, MedAvante Inc, Quest Diagnostics Incorporated, ProPhase LLC, Signant Health, Linus Health, Posit Science, Clario, Cognetivity Neurosciences, Pear Therapeutics, Akili Interactive Labs and CNS Vital Signs LLC.

Key Developments:

In May 2023, Linus Health, a digital health solution provider, announced the result of its digital cognitive assessment solution study with a commonly used, paper-based cognitive test, the Mini-Mental State Examination (MMSE), in detecting cognitive cases of impairment. This solution helps in the earlier identification of cognitive issues.

In January 2022, Eisai Limited announced the launch of CogMate by its Taiwanese and Hong Kong subsidiaries. CogMate is a digital tool for self-assessment of brain health and is expected to be launched in other countries including Singapore.

Components Covered:

• Solutions
• Services

Assessments Covered:

• Pen & Paper Based Assessment
• Hosted Assessment
• Biometrics Assessment

Applications Covered:

• Clinical Trials
• Screening & Diagnostic
• Brain Training
• Academic Research
• Learning Disabilities
• Stroke Rehabilitation
• Other Applications

End Users Covered:

• Healthcare
• Research Organization
• Education
• Rehabilitation Centers
• Corporate Wellness Programs
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Cognitive Assessment & Training In Healthcare Market, By Component

• 5.1 Introduction
• 5.2 Solutions
  • 5.2.1 Project Management
  • 5.2.2 Data Analysis & Reporting
  • 5.2.3 Data Management
  • 5.2.4 Cognitive Training
• 5.3 Services
  • 5.3.1 Training & Support
  • 5.3.2 Consulting

6 Global Cognitive Assessment & Training In Healthcare Market, By Assessment

• 6.1 Introduction
• 6.2 Pen & Paper Based Assessment
• 6.3 Hosted Assessment
• 6.4 Biometrics Assessment

7 Global Cognitive Assessment & Training In Healthcare Market, By Application

• 7.1 Introduction
• 7.2 Clinical Trials
• 7.3 Screening & Diagnostic
• 7.4 Brain Training
• 7.5 Academic Research
• 7.6 Learning Disabilities
• 7.7 Stroke Rehabilitation
• 7.8 Other Applications

8 Global Cognitive Assessment & Training In Healthcare Market, By End User

• 8.1 Introduction
• 8.2 Healthcare
• 8.3 Research Organization
• 8.4 Education
• 8.5 Rehabilitation Centers
• 8.6 Corporate Wellness Programs
• 8.7 Other End Users

9 Global Cognitive Assessment & Training In Healthcare Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Cambridge Cognition Limited
• 11.2 Cognifit Inc
• 11.3 Cogstate Limited
• 11.4 Eisai Limited
• 11.5 Brain Resource Company
• 11.6 Wirb-Copernicus Group
• 11.7 MedAvante Inc
• 11.8 Quest Diagnostics Incorporated
• 11.9 ProPhase LLC
• 11.10 Signant Health
• 11.11 Linus Health
• 11.12 Posit Science
• 11.13 Clario
• 11.14 Cognetivity Neurosciences
• 11.15 Pear Therapeutics
• 11.16 Akili Interactive Labs
• 11.17 CNS Vital Signs LLC